Advancing mitochondria as a therapeutic agent

This article intends to provide an update of the needs in the field working in the artificial mitochondrial transfer/transplant (AMT/T), and an overview of the highlights from the articles in the special issue “Advances of Mitochondria as a therapeutic agent”. In the last 4 decades, scientists have...

Full description

Saved in:
Bibliographic Details
Published in:Mitochondrion 2023-03, Vol.69, p.33-35
Main Authors: Caicedo, Andrés, Singh, Keshav K.
Format: Article
Language:English
Subjects:
Humans
Mitochondria
Reperfusion Injury - therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This article intends to provide an update of the needs in the field working in the artificial mitochondrial transfer/transplant (AMT/T), and an overview of the highlights from the articles in the special issue “Advances of Mitochondria as a therapeutic agent”. In the last 4 decades, scientists have developed innovative therapeutic applications based on the AMT/T, inspired by the natural transfer of mitochondria between cells to repair cellular damage or treat diseases. The clinical application of AMT has become the priority for the field involving the replacement or augmentation of healthy mitochondria in the harmed tissue, especially in the treatment of organ ischemia–reperfusion injury. However, we remark in our article that key questions remain to be answered such as which one is the best isolation protocol, tissue or cell source for isolation, and others of great importance to move the field forward.
ISSN:1567-7249
1872-8278
DOI:10.1016/j.mito.2023.01.003